EUVIMEDEUVIMED entdecken
Crossref

Pharmacological Investigation of Methanolic Extract of Gmelina arborea for Anxiolytic Activity and Neurotransmitter Modulation

Ms. Pranali V. Patil, Sharayu D. Ingale, Ms. Shradha D. Shirdhone, Ms. Shreshtha U. Kadam, Mrs Tejashree S. Khamkar, Ms.Dhanashree A. Ghatage, Dr. Snehal D. Dherange, Ms. Mrunal C. Belwate

International Journal of Drug Delivery Technology · 31.03.2026 · 16 (3s)

DOI: 10.25258/ijddt.16.3s.39 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 31.03.2026. Verfasst von Ms. Pranali V. Patil und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Anxiety disorders are prevalent neuropsychiatric conditions associated with oxidative stress and neurotransmitter imbalance, particularly gamma-aminobutyric acid (GABA) and serotonin. Herbal medicines with antioxidant and neuroprotective properties may offer safer therapeutic alternatives. The present study investigated the anxiolytic potential of the methanolic extract of Gmelina arborea (MEGA) in stress-induced murine models. Materials and Methodology: Acute oral toxicity was evaluated as per OECD guidelines. Swiss albino mice (25–35 g) were subjected to electric foot shock and restraint stress-induced anxiety models. Behavioral assessments were conducted using the Elevated Plus Maze (EPM) and Light–Dark Transition (LDT) tests. MEGA was administered orally at doses of 200 and 400 mg/kg, while Diazepam (1 mg/kg) served as the standard. In vitro antioxidant activity was assessed using DPPH, hydrogen peroxide, and nitric oxide scavenging assays. Neuroprotective activity was evaluated in SH-SY5Y neuroblastoma cells exposed to H₂O₂-induced oxidative stress. Brain GABA and serotonin levels were estimated posttreatment.

Results

MEGA was safe up to 2000 mg/kg with no mortality observed. The extract exhibited dose-dependent antioxidant activity and significant protection against oxidative stress in SH-SY5Y cells. In vivo studies demonstrated a significant increase (p < 0.05) in time spent in open arms (EPM) and light compartment (LDT) compared to disease control. Biochemical analysis revealed restoration of GABA and serotonin levels comparable to Diazepam-treated groups.

Conclusion

The findings confirm that Gmelina arborea possesses significant anxiolytic, antioxidant, and neuroprotective properties, supporting its potential as a natural therapeutic candidate for anxiety disorders.

Zitieren

APA

Patil, M. P. V., Ingale, S. D., Shirdhone, M. S. D., Kadam, M. S. U., Khamkar, M. T. S., Ghatage, M. A., Dherange, D. S. D., & Belwate, M. M. C. (2026). Pharmacological Investigation of Methanolic Extract of Gmelina arborea for Anxiolytic Activity and Neurotransmitter Modulation. International Journal of Drug Delivery Technology, 16(3s). https://doi.org/10.25258/ijddt.16.3s.39

Vancouver

Patil MPV, Ingale SD, Shirdhone MSD, Kadam MSU, Khamkar MTS, Ghatage MA, et al. Pharmacological Investigation of Methanolic Extract of Gmelina arborea for Anxiolytic Activity and Neurotransmitter Modulation. International Journal of Drug Delivery Technology. 2026;16(3s). doi:10.25258/ijddt.16.3s.39

BibTeX
@article{Patil2026,
  author = {Patil, Ms. Pranali V. and Ingale, Sharayu D. and Shirdhone, Ms. Shradha D. and Kadam, Ms. Shreshtha U. and Khamkar, Mrs Tejashree S. and Ghatage, Ms.Dhanashree A. and Dherange, Dr. Snehal D. and Belwate, Ms. Mrunal C.},
  title = {Pharmacological Investigation of Methanolic Extract of Gmelina arborea for Anxiolytic Activity and Neurotransmitter Modulation},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {3s},
  doi = {10.25258/ijddt.16.3s.39}
}
Kostenlos starten →